Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Pharmaceuticals SPDR
(NY:
XPH
)
43.03
-0.25 (-0.58%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about S&P Pharmaceuticals SPDR
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
July 26, 2024
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.
Via
MarketBeat
Topics
ETFs
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
June 27, 2024
The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,...
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Pharma ETFs have delivered mixed performances over the past month.
Via
Talk Markets
Topics
ETFs
Organon Beats On Q1, Women's Health Leads the Charge
May 02, 2024
Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of bu...
Via
Benzinga
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth.
Via
Talk Markets
Topics
ETFs
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Pharma ETFs have been in the green over the past month.
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
3 Pharma Stocks Yielding Over 3%
January 18, 2022
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.
Via
Talk Markets
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
The Bear Market Is Already Here – But Not For Dividend Investors
December 22, 2021
While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months.
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.
Via
Talk Markets
The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour
August 20, 2021
the Fed has bought $4 trillion bonds in the past 18 months, twice the amount the US spent on War in Afghanistan past 20 years as it, and other global central banks, have spent $834 million every hour...
Via
Talk Markets
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
The 2 Best Pharma Stocks to Buy on Dips
June 23, 2021
Because the COVID-19 pandemic is under control in most major economies, the hype surrounding vaccine producers is gradually tapering off.
Via
Talk Markets
Exposures
COVID-19
3 Top Pharma Stocks to Buy This Month
June 09, 2021
In 2020, pharmaceutical stocks came to the forefront as healthcare companies were searching for treatments for COVID-19.
Via
Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound.
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.